Ankylosing spondylitis (AS) is a chronic, inflammatory type of arthritis that primarily affects the spine and sacroiliac joints. It is a progressive condition that causes pain and stiffness in the spine, hips, and shoulders. The pain and stiffness associated with AS can be severe and can significantly impact a person’s quality of life. Treatment for AS includes medications, physical therapy, and lifestyle modifications. Recently, new treatments have been developed that may be more effective in managing the symptoms of AS. This article provides a comprehensive guide to exploring new treatment options for ankylosing spondylitis.
Medications are the mainstay of treatment for AS. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce inflammation and pain. These medications are available over-the-counter or by prescription. Other medications, such as disease-modifying anti-rheumatic drugs (DMARDs) or biologic response modifiers, may be prescribed to slow the progression of AS. DMARDs work by blocking the action of certain proteins that cause inflammation. Biologic response modifiers are newer medications that work by targeting specific parts of the immune system.
Physical therapy is an important part of treatment for AS. Physical therapists can teach patients exercises that can help reduce pain and improve mobility. The exercises may include stretching, strengthening, and aerobic activities. Physical therapists can also teach patients how to use assistive devices, such as canes or braces, to help manage their symptoms.
Lifestyle modifications are also important in managing the symptoms of AS. These modifications may include avoiding activities that can worsen symptoms, such as strenuous exercise or heavy lifting. It is important to maintain a healthy weight, as being overweight can worsen symptoms. It is also important to get enough rest and to practice stress-reduction techniques, such as yoga or meditation.
In recent years, new treatments for AS have been developed. One such treatment is the use of intra-articular injections. These injections are given directly into the affected joint and contain a steroid to reduce inflammation. Other treatments include the use of stem cell therapy and platelet-rich plasma (PRP) injections. Stem cell therapy involves injecting stem cells into the affected joint to promote healing. PRP injections are injections of platelets and growth factors that can help reduce inflammation and promote healing.
Ankylosing spondylitis is a chronic, inflammatory type of arthritis that can cause significant pain and stiffness. Treatment for AS includes medications, physical therapy, and lifestyle modifications. Recently, new treatments have been developed that may be more effective in managing the symptoms of AS. This article provided a comprehensive guide to exploring new treatment options for ankylosing spondylitis. With the help of a healthcare professional, patients can find the best treatment plan to help manage their symptoms.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation